AYTU BIOPHARMA, INC Increase (Decrease) in Derivative Liabilities
AYTU BIOPHARMA, INC (AYTU) reported Increase (Decrease) in Derivative Liabilities of $102.93 thousand for the 3-month period ending 2015-09-30, per its 10-Q filed 2015-11-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeLiabilities · last filed 2015-11-06
- AYTU BIOPHARMA, INC increase (decrease) in derivative liabilities for the quarter ending 2015-09-30 was $102.93K.
| Period end | Increase (Decrease) in Derivative Liabilities 3 month |
|---|---|
| 2015-09-30 | $102.93K 10-Q · filed 2015-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |